Coon, B. G., Timalsina, S., Astone, M., Zhuang, Z. W., Fang, J., Han, J., Themen, J., Chung, M., Yang-Klingler, Y. J., Jain, M., Hirschi, K. K., Yamamato, A., Trudeau, L.-E., Santoro, M., & Schwartz, M. A. (2022). A mitochondrial contribution to anti-inflammatory shear stress signaling in vascular endothelial cells. Journal of Cell Biology, 221(7). https://doi.org/10.1083/jcb.202109144

Miceli, F., Millevert, C., Soldovieri, M. V., Mosca, I., Ambrosino, P., Carotenuto, L., Schrader, D., Lee, H. K., Riviello, J., Hong, W., Risen, S., Emrick, L., Amin, H., Ville, D., Edery, P., de Bellescize, J., Michaud, V., Van-Gils, J., Goizet, C., … Weckhuysen, S. (2022). KCNQ2 R144 variants cause neurodevelopmental disability with language impairment and autistic features without neonatal seizures through a gain-of-function mechanism. EBioMedicine, 81, 104130. https://doi.org/10.1016/j.ebiom.2022.104130

Lee, A. J., Raghavan, N. S., Bhattarai, P., Siddiqui, T., Sariya, S., Reyes-Dumeyer, D., Flowers, X. E., Cardoso, S. A. L., De Jager, P. L., Bennett, D. A., Schneider, J. A., Menon, V., Wang, Y., Lantigua, R. A., Medrano, M., Rivera, D., Jiménez-Velázquez, I. Z., Kukull, W. A., Brickman, A. M., … Mayeux, R. (2022). FMNL2 regulates gliovascular interactions and is associated with vascular risk factors and cerebrovascular pathology in Alzheimer’s disease. Acta Neuropathologica, 144(1), 59–79. https://doi.org/10.1007/s00401-022-02431-6

Balomenos, V., Bounou, L., Charisis, S., Stamelou, M., Ntanasi, E., Georgiadi, K., Mourtzinos, I., Tzima, K., Anastasiou, C. A., Xiromerisiou, G., Maraki, M., Yannakoulia, M., Kosmidis, M. H., Dardiotis, E., Hadjigeorgiou, G., Sakka, P., Stefanis, L., & Scarmeas, N. (2022). Dietary Inflammatory Index score and prodromal Parkinson’s disease incidence: The HELIAD study. The Journal of Nutritional Biochemistry, 105, 108994. https://doi.org/10.1016/j.jnutbio.2022.108994

Striano, P., Auvin, S., Collins, A., Horvath, R., Scheffer, I. E., Tzadok, M., Miller, I., Kay Koenig, M., Lacy, A., Davis, R., Garcia‐Cazorla, A., Saneto, R. P., Brandabur, M., Blair, S., Koutsoukos, T., & De Vivo, D. (2022). A randomized, double‐blind trial of triheptanoin for drug‐resistant epilepsy in glucose transporter 1 deficiency syndrome. Epilepsia, 63(7), 1748–1760. Portico. https://doi.org/10.1111/epi.17263

Eissman, J. M., Dumitrescu, L., Mahoney, E. R., Smith, A. N., Mukherjee, S., Lee, M. L., Scollard, P., Choi, S. E., Bush, W. S., Engelman, C. D., Lu, Q., Fardo, D. W., Trittschuh, E. H., Mez, J., Kaczorowski, C. C., Hernandez Saucedo, H., Widaman, K. F., Buckley, R. F., Properzi, M. J., … Hohman, T. J. (2022). Sex differences in the genetic architecture of cognitive resilience to Alzheimer’s disease. Brain, 145(7), 2541–2554. https://doi.org/10.1093/brain/awac177

Mamalaki, E., Charisis, S., Anastasiou, C. A., Ntanasi, E., Georgiadi, K., Balomenos, V., Kosmidis, M. H., Dardiotis, E., Hadjigeorgiou, G., Sakka, P., Scarmeas, N., & Yannakoulia, M. (2022). The Longitudinal Association of Lifestyle with Cognitive Health and Dementia Risk: Findings from the HELIAD Study. Nutrients, 14(14), 2818. https://doi.org/10.3390/nu14142818

Le Guen, Y., Belloy, M. E., Grenier-Boley, B., de Rojas, I., Castillo-Morales, A., Jansen, I., Nicolas, A., Bellenguez, C., Dalmasso, C., Küçükali, F., Eger, S. J., Rasmussen, K. L., Thomassen, J. Q., Deleuze, J.-F., He, Z., Napolioni, V., Amouyel, P., Jessen, F., Kehoe, P. G., … Rujescu, D. (2022). Association of Rare APOE Missense Variants V236E and R251G With Risk of Alzheimer Disease. JAMA Neurology, 79(7), 652. https://doi.org/10.1001/jamaneurol.2022.1166

Pouliopoulos, A. N., Murillo, M. F., Noel, R. L., Batts, A. J., Ji, R., Kwon, N., Yu, H., Tong, C.-K., Gelinas, J. N., Araghy, D. K., Hussaini, S. A., & Konofagou, E. E. (2022). Non-invasive optogenetics with ultrasound-mediated gene delivery and red-light excitation. Brain Stimulation, 15(4), 927–941. https://doi.org/10.1016/j.brs.2022.06.007

Hartley, S. L., Fleming, V., Piro-Gambetti, B., Cohen, A., Ances, B. M., Yassa, M. A., Brickman, A. M., Handen, B. L., Head, E., Mapstone, M., Christian, B. T., Lott, I. T., Doran, E., Zaman, S., Krinsky-McHale, S., Schmitt, F. A., Hom, C., & Schupf, N. (2022). Impact of the COVID-19 pandemic on daily life, mood, and behavior of adults with Down syndrome. Disability and Health Journal, 15(3), 101278. https://doi.org/10.1016/j.dhjo.2022.101278

Ling, W., Cheng, B., Wei, Y., Willey, J., & Cheung, Y. K. (2022). STATISTICAL INFERENCE IN QUANTILE REGRESSION FOR ZERO-INFLATED OUTCOMES. Statistica Sinica. https://doi.org/10.5705/ss.202020.0368

Omran, S. S., Khasiyev, F., Zhang, C., Rundek, T., Sacco, R. L., Wright, C. B., Elkind, M. S. V., & Gutierrez, J. (2022). Anatomical effects on the relationship between brain arterial diameter and length: The Northern Manhattan Study. Journal of Neuroimaging, 32(4), 735–743. Portico. https://doi.org/10.1111/jon.12969

Hunter, M. D., Kulick, E. R., Miller, E., Willey, J., Boehme, A. K., Branas, C., & Elkind, M. S. V. (2022). Rural-Urban Differences in Diagnosed Cervical Artery Dissection in New York State. Cerebrovascular Diseases, 51(4), 506–510. Portico. https://doi.org/10.1159/000521204

Strauss, K. A., Farrar, M. A., Muntoni, F., Saito, K., Mendell, J. R., Servais, L., McMillan, H. J., Finkel, R. S., Swoboda, K. J., Kwon, J. M., Zaidman, C. M., Chiriboga, C. A., Iannaccone, S. T., Krueger, J. M., Parsons, J. A., Shieh, P. B., Kavanagh, S., Tauscher-Wisniewski, S., McGill, B. E., & Macek, T. A. (2022). Onasemnogene abeparvovec for presymptomatic infants with two copies of SMN2 at risk for spinal muscular atrophy type 1: the Phase III SPR1NT trial. Nature Medicine, 28(7), 1381–1389. https://doi.org/10.1038/s41591-022-01866-4

Ruan, C., & Elyaman, W. (2022). A New Understanding of TMEM119 as a Marker of Microglia. Frontiers in Cellular Neuroscience, 16. https://doi.org/10.3389/fncel.2022.902372

Benatar, M., Wuu, J., Andersen, P. M., Bucelli, R. C., Andrews, J. A., Otto, M., Farahany, N. A., Harrington, E. A., Chen, W., Mitchell, A. A., Ferguson, T., Chew, S., Gedney, L., Oakley, S., Heo, J., Chary, S., Fanning, L., Graham, D., Sun, P., … Fradette, S. (2022). Design of a Randomized, Placebo-Controlled, Phase 3 Trial of Tofersen Initiated in Clinically Presymptomatic SOD1 Variant Carriers: the ATLAS Study. Neurotherapeutics, 19(4), 1248–1258. https://doi.org/10.1007/s13311-022-01237-4

Strauss, K. A., Farrar, M. A., Muntoni, F., Saito, K., Mendell, J. R., Servais, L., McMillan, H. J., Finkel, R. S., Swoboda, K. J., Kwon, J. M., Zaidman, C. M., Chiriboga, C. A., Iannaccone, S. T., Krueger, J. M., Parsons, J. A., Shieh, P. B., Kavanagh, S., Wigderson, M., Tauscher-Wisniewski, S., … Macek, T. A. (2022). Onasemnogene abeparvovec for presymptomatic infants with three copies of SMN2 at risk for spinal muscular atrophy: the Phase III SPR1NT trial. Nature Medicine, 28(7), 1390–1397. https://doi.org/10.1038/s41591-022-01867-3

Darras, B. T., Guye, S., Hoffart, J., Schneider, S., Gravestock, I., Gorni, K., Fuerst‐Recktenwald, S., Scalco, R. S., Finkel, R. S., & De Vivo, D. C. (2022). Distribution of weight, stature, and growth status in children and adolescents with spinal muscular atrophy: An observational retrospective study in the United States. Muscle & Nerve, 66(1), 84–90. Portico. https://doi.org/10.1002/mus.27556

Yalcouyé, A., Traoré, O., Diarra, S., Schrauwen, I., Esoh, K., Kadlubowska, M. K., Bharadwaj, T., Adadey, S. M., Kéita, M., Guinto, C. O., Leal, S. M., Landouré, G., & Wonkam, A. (2022). A monoallelic variant in EYA1 is associated with Branchio‐Otic syndrome in a Malian family. Molecular Genetics & Genomic Medicine, 10(7). Portico. https://doi.org/10.1002/mgg3.1995

Peterson, A., Gottesman, R. T., Miller, E. C., & Tom, S. E. (2022). The association of vasomotor symptoms during the menopausal transition and cognition in later life. Menopause, 29(7), 832–839. https://doi.org/10.1097/gme.0000000000001986

Berardo, A., Li, S., & Hirano, M. (2022). Encefalomalacia multiquística en la encefalomiopatía mitocondrial, acidosis láctica y episodios stroke like (MELAS). Neurología Argentina, 14(3), 195–196. https://doi.org/10.1016/j.neuarg.2022.05.003

Higgins-Chen, A. T., Thrush, K. L., Wang, Y., Minteer, C. J., Kuo, P.-L., Wang, M., Niimi, P., Sturm, G., Lin, J., Moore, A. Z., Bandinelli, S., Vinkers, C. H., Vermetten, E., Rutten, B. P. F., Geuze, E., Okhuijsen-Pfeifer, C., van der Horst, M. Z., Schreiter, S., Gutwinski, S., … Levine, M. E. (2022). A computational solution for bolstering reliability of epigenetic clocks: implications for clinical trials and longitudinal tracking. Nature Aging, 2(7), 644–661. https://doi.org/10.1038/s43587-022-00248-2

PJ, J., AM, T., RE, S., LD, S., R, G., L, B., C, M., M, E., EP, P., J, B., S, K., C, O., CT, T., & Guzik, A. K. (2022). Inpatient Telemedicine for Neurology Consultation at Satellite Hospitals: Patient and Provider Perspectives. The Neurohospitalist, 12(3), 476–483. https://doi.org/10.1177/19418744221100364

Samieri, C., Yassine, H. N., Melo van Lent, D., Lefèvre‐Arbogast, S., van de Rest, O., Bowman, G. L., & Scarmeas, N. (2021). Personalized nutrition for dementia prevention. Alzheimer’s & Dementia, 18(7), 1424–1437. Portico. https://doi.org/10.1002/alz.12486

Acharya, A., Kavus, H., Dunn, P., Nasir, A., Folk, L., Withrow, K., Wentzensen, I. M., Ruzhnikov, M. R. Z., Fallot, C., Smol, T., Rama, M., Brown, K., Whalen, S., Ziegler, A., Barth, M., Chassevent, A., Smith-Hicks, C., Afenjar, A., Courtin, T., … Schrauwen, I. (2021). Delineating the genotypic and phenotypic spectrum of HECW2-related neurodevelopmental disorders. Journal of Medical Genetics, 59(7), 669–677. https://doi.org/10.1136/jmedgenet-2021-107871

Oliver, K. L., Ellis, C. A., Scheffer, I. E., Ganesan, S., Leu, C., Sadleir, L. G., Heinzen, E. L., Mefford, H. C., Bass, A. J., Curtis, S. W., Harris, R. V., Whiteman, D. C., Helbig, I., Ottman, R., Epstein, M. P., Bahlo, M., & Berkovic, S. F. (2022). Common risk variants for epilepsy are enriched in families previously targeted for rare monogenic variant discovery. EBioMedicine, 81, 104079. https://doi.org/10.1016/j.ebiom.2022.104079

Lin, C. R., Viswanathan, A., Chen, T. X., Mitsumoto, H., Vonsattel, J. P., Faust, P. L., & Kuo, S. (2022). Clinicopathological correlates of pyramidal signs in multiple system atrophy. Annals of Clinical and Translational Neurology, 9(7), 988–994. Portico. https://doi.org/10.1002/acn3.51576

Fang, Y., Idnay, B., Sun, Y., Liu, H., Chen, Z., Marder, K., Xu, H., Schnall, R., & Weng, C. (2022). Combining human and machine intelligence for clinical trial eligibility querying. Journal of the American Medical Informatics Association, 29(7), 1161–1171. https://doi.org/10.1093/jamia/ocac051

Wu, X., Sosunov, A. A., Lado, W., Teoh, J. J., Ham, A., Li, H., Al-Dalahmah, O., Gill, B. J. A., Arancio, O., Schevon, C. A., Frankel, W. N., McKhann, G. M., Sulzer, D., Goldman, J. E., & Tang, G. (2022). Synaptic hyperexcitability of cytomegalic pyramidal neurons contributes to epileptogenesis in tuberous sclerosis complex. Cell Reports, 40(3), 111085. https://doi.org/10.1016/j.celrep.2022.111085

Miller, R. G., Zhang, R., Bracci, P. M., Azhir, A., Barohn, R., Bedlack, R., Benatar, M., Berry, J. D., Cudkowicz, M., Kasarskis, E. J., Mitsumoto, H., Manousakis, G., Walk, D., Oskarsson, B., Shefner, J., & McGrath, M. S. (2022). Phase 2B randomized controlled trial of NP001 in amyotrophic lateral sclerosis: Pre‐specified and post hoc analyses. Muscle & Nerve, 66(1), 39–49. Portico. https://doi.org/10.1002/mus.27511

Geronikola, N., Zalonis, I., Ntanasi, E., Charisis, S., Kosmidis, M. H., Anastasiou, C. A., Dardiotis, E., Hadjigeorgiou, G., Megalou, M., Velonakis, G., Karavasilis, E., Gargalionis, A. N., Patas, K., Piperidi, A., Chatzipanagiotou, S., Sakka, P., Paraskevas, G., Yannakoulia, M., & Scarmeas, N. (2022). Sex Differences in Frailty Incidence in Greek Community-Dwelling Older People: The HELIAD Study. Journal of Frailty & Aging. https://doi.org/10.14283/jfa.2022.39

Shintaku, J., Pernice, W. M., Eyaid, W., GC, J. B., Brown, Z. P., Juanola-Falgarona, M., Torres-Torronteras, J., Sommerville, E. W., Hellebrekers, D. M. E. I., Blakely, E. L., Donaldson, A., van de Laar, I., Leu, C.-S., Marti, R., Frank, J., Tanji, K., Koolen, D. A., Rodenburg, R. J., Chinnery, P. F., … Hirano, M. (2022). RRM1 variants cause a mitochondrial DNA maintenance disorder via impaired de novo nucleotide synthesis. Journal of Clinical Investigation, 132(13). https://doi.org/10.1172/jci145660

Oelsner, E. C., Krishnaswamy, A., Balte, P. P., Allen, N. B., Ali, T., Anugu, P., Andrews, H. F., Arora, K., Asaro, A., Barr, R. G., Bertoni, A. G., Bon, J., Boyle, R., Chang, A. A., Chen, G., Coady, S., Cole, S. A., Coresh, J., … Cornell, E. (2022). Collaborative Cohort of Cohorts for COVID-19 Research (C4R) Study: Study Design. American Journal of Epidemiology, 191(7), 1153–1173. https://doi.org/10.1093/aje/kwac032

Austin, T. R., McHugh, C. P., Brody, J. A., Bis, J. C., Sitlani, C. M., Bartz, T. M., Biggs, M. L., Bansal, N., Buzkova, P., Carr, S. A., deFilippi, C. R., Elkind, M. S. V., Fink, H. A., Floyd, J. S., Fohner, A. E., Gerszten, R. E., Heckbert, S. R., Katz, D. H., Kizer, J. R., … Psaty, B. M. (2022). Proteomics and Population Biology in the Cardiovascular Health Study (CHS): design of a study with mentored access and active data sharing. European Journal of Epidemiology, 37(7), 755–765. https://doi.org/10.1007/s10654-022-00888-z

Kever, A., Riley, C. S., & Leavitt, V. M. (2022). Diagnosis concealment is associated with psychosocial outcomes in persons with multiple sclerosis. Multiple Sclerosis Journal, 28(8), 1311–1314. https://doi.org/10.1177/13524585211070496

Yang, J. M., Moon, S. Y., Lee, J. Y., Agalliu, D., Yon, D. K., & Lee, S. W. (2022). COVID-19 Morbidity and Severity in Patients With Age-Related Macular Degeneration: A Korean Nationwide Cohort Study. American Journal of Ophthalmology, 239, 159–169. https://doi.org/10.1016/j.ajo.2021.05.024

Campisi, L., Chizari, S., Ho, J. S. Y., Gromova, A., Arnold, F. J., Mosca, L., Mei, X., Fstkchyan, Y., Torre, D., Beharry, C., Garcia-Forn, M., Jiménez-Alcázar, M., Korobeynikov, V. A., Prazich, J., Fayad, Z. A., Seldin, M. M., De Rubeis, S., Bennett, C. L., Ostrow, L. W., … Marazzi, I. (2022). Clonally expanded CD8 T cells characterize amyotrophic lateral sclerosis-4. Nature, 606(7916), 945–952. https://doi.org/10.1038/s41586-022-04844-5

Habeck, C., Gazes, Y., & Stern, Y. (2022). Age-Specific Activation Patterns and Inter-Subject Similarity During Verbal Working Memory Maintenance and Cognitive Reserve. Frontiers in Psychology, 13. https://doi.org/10.3389/fpsyg.2022.852995

Consens, M. E., Chen, Y., Menon, V., Wang, Y., Schneider, J. A., De Jager, P. L., Bennett, D. A., Tripathy, S. J., & Felsky, D. (2022). Bulk and Single-Nucleus Transcriptomics Highlight Intra-Telencephalic and Somatostatin Neurons in Alzheimer’s Disease. Frontiers in Molecular Neuroscience, 15. https://doi.org/10.3389/fnmol.2022.903175

Pérez-Torres, E. J., Utkina-Sosunova, I., Mishra, V., Barbuti, P., De Planell-Saguer, M., Dermentzaki, G., Geiger, H., Basile, A. O., Robine, N., Fagegaltier, D., Politi, K. A., Rinchetti, P., Jackson-Lewis, V., Harms, M., Phatnani, H., Lotti, F., Przedborski, S., Phatnani, H., … Traynor, B. J. (2022). Retromer dysfunction in amyotrophic lateral sclerosis. Proceedings of the National Academy of Sciences, 119(26). https://doi.org/10.1073/pnas.2118755119

Cosentino, S., & Shih, L. C. (2022). Does essential tremor increase risk of cognitive impairment and dementia? Yes. Essential Tremor: Current Concepts and Controversies, 195–231. https://doi.org/10.1016/bs.irn.2022.02.011

Bose, K., Maity, A., Ngo, K. H., Vandana, J. J., Shneider, N. A., & Phan, A. T. (2022). Formation of RNA G-wires by G4C2 repeats associated with ALS and FTD. Biochemical and Biophysical Research Communications, 610, 113–118. https://doi.org/10.1016/j.bbrc.2022.03.162

Caldwell, M., Boruah, A. P., & Thakur, K. T. (2022). Acute neurologic emerging flaviviruses. Therapeutic Advances in Infectious Disease, 9. https://doi.org/10.1177/20499361221102664

Inglese, M., Patel, N., Linton-Reid, K., Loreto, F., Win, Z., Perry, R. J., Carswell, C., Grech-Sollars, M., Crum, W. R., Lu, H., Malhotra, P. A., Silbert, L. C., Lind, B., Crissey, R., Kaye, J. A., Carter, R., Dolen, S., Quinn, J., … Aboagye, E. O. (2022). A predictive model using the mesoscopic architecture of the living brain to detect Alzheimer’s disease. Communications Medicine, 2(1). https://doi.org/10.1038/s43856-022-00133-4

Kalia, V., Niedzwiecki, M. M., Bradner, J. M., Lau, F. K., Anderson, F. L., Bucher, M. L., Manz, K. E., Schlotter, A. P., Fuentes, Z. C., Pennell, K. D., Picard, M., Walker, D. I., Hu, W. T., Jones, D. P., & Miller, G. W. (2022). Cross-species metabolomic analysis of tau- and DDT-related toxicity. PNAS Nexus, 1(2). https://doi.org/10.1093/pnasnexus/pgac050

de Prisco, N., Botta, S., Lee, W., Rezazadeh, S., Chemiakine, A., & Gennarino, V. A. (2022). Determining the effects of loss of function mutations in human cell lines. STAR Protocols, 3(2), 101232. https://doi.org/10.1016/j.xpro.2022.101232

Botta, S., Chemiakine, A., & Gennarino, V. A. (2022). Dual antibody strategy for high-resolution imaging of murine Purkinje cells and their dendrites across multiple layers. STAR Protocols, 3(2), 101427. https://doi.org/10.1016/j.xpro.2022.101427

Wang, Q., de Prisco, N., Tang, J., & Gennarino, V. A. (2022). Protocol for recording epileptiform discharges of EEG and behavioral seizures in freely moving mice. STAR Protocols, 3(2), 101245. https://doi.org/10.1016/j.xpro.2022.101245

de Prisco, N., Chemiakine, A., Lee, W., Botta, S., & Gennarino, V. A. (2022). Protocol to assess the effect of disease-driving variants on mouse brain morphology and primary hippocampal neurons. STAR Protocols, 3(2), 101244. https://doi.org/10.1016/j.xpro.2022.101244

Yang, D., & Masurkar, A. (2022). Early-Stage MRI Volumetric Differences in White Matter Hyperintensity and Temporal Lobe Volumes between Autopsy-Confirmed Alzheimer’s Disease, Cerebral Small Vessel Disease, and Mixed Pathologies. Dementia and Geriatric Cognitive Disorders Extra, 12(1), 69–75. Portico. https://doi.org/10.1159/000524499